Makoto Tsuda Selected Research

Adenosine Triphosphate (ATP)

1/2021	Nociceptive signaling mediated by P2X3, P2X4 and P2X7 receptors.
1/2018	[Green Pharma: A New Strategy for Drug Discovery in Academia by Targeting Glial Cells and ATP Receptors].
1/2017	Fibromyalgia and microglial TNF-α: Translational research using human blood induced microglia-like cells.
12/2016	Dorsal horn neurons release extracellular ATP in a VNUT-dependent manner that underlies neuropathic pain.
10/2016	Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia.
1/2016	A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain.
1/2016	Microglia in the spinal cord and neuropathic pain.
8/2012	Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain.
6/2012	CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia.
5/2010	Pain and purinergic signaling.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Tsuda Research Topics

Disease

54	Neuralgia (Stump Neuralgia) 01/2023 - 02/2004
48	Pain (Aches) 01/2023 - 05/2002
38	Hyperalgesia 12/2022 - 08/2003
23	Hypersensitivity (Allergy) 01/2023 - 01/2004
22	Peripheral Nerve Injuries 01/2023 - 08/2003
20	Chronic Pain 01/2021 - 01/2004
5	Inflammation (Inflammations) 01/2016 - 11/2007
4	Neoplasms (Cancer) 07/2020 - 08/2014
3	Hypertension (High Blood Pressure) 12/2017 - 01/2016
3	Acute Pain 01/2016 - 08/2003
2	Contact Dermatitis (Eczema, Contact) 01/2021 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2019 - 08/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 06/2017
1	Pathologic Constriction (Stenosis) 10/2020
1	Spinal Cord Compression 10/2020
1	Neuroinflammatory Diseases 07/2020
1	Muscular Atrophy (Muscle Atrophy) 01/2020
1	Contracture 01/2020
1	Heart Failure 01/2020

Drug/Important Bio-Agent (IBA)

19	Adenosine Triphosphate (ATP)IBA 01/2021 - 05/2002
14	Purinergic P2 Receptors (ADP Receptor)IBA 11/2012 - 08/2003
12	Purinergic P2X4 ReceptorsIBA 01/2022 - 05/2006
11	Purinergic Receptors (Receptors, Purine)IBA 01/2021 - 02/2005
8	Analgesics (Analgesic Drugs)IBA 12/2022 - 04/2009
7	CytokinesIBA 01/2018 - 03/2007
6	p38 Mitogen-Activated Protein KinasesIBA 03/2007 - 01/2004
5	NucleotidesIBA 01/2021 - 06/2005
5	Proteins (Proteins, Gene)FDA Link 07/2020 - 07/2006
5	CationsIBA 01/2018 - 05/2006
4	Duloxetine Hydrochloride (Cymbalta)FDA Link 12/2022 - 01/2016
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2022 - 01/2016
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 02/2015
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 05/2014
4	ChemokinesIBA 01/2017 - 09/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 03/2007
4	Opioid Analgesics (Opioids)IBA 01/2017 - 04/2009
4	SB 203580IBA 03/2007 - 01/2004
3	Monoclonal AntibodiesIBA 01/2022 - 03/2013
3	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2007
3	Capsaicin (Zostrix)FDA Link 11/2020 - 05/2002
3	purinoceptor P2Y6IBA 01/2020 - 01/2016
3	Messenger RNA (mRNA)IBA 11/2018 - 07/2006
3	InterleukinsIBA 01/2018 - 03/2007
3	GTP-Binding Proteins (G-Protein)IBA 12/2017 - 01/2016
3	gamma-Aminobutyric Acid (GABA)IBA 12/2012 - 12/2005
3	Freund's AdjuvantIBA 08/2012 - 11/2007
3	Formaldehyde (Formol)FDA Link 07/2011 - 05/2002
3	Fibronectins (Fibronectin)IBA 04/2008 - 05/2006
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023 - 01/2021
2	EnzymesIBA 01/2023 - 08/2012
2	Antidepressive Agents (Antidepressants)IBA 12/2022 - 04/2009
2	UridineIBA 01/2020 - 12/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2019 - 11/2018
2	AntibodiesIBA 01/2019 - 03/2007
2	AngiotensinsIBA 12/2017 - 01/2016
2	N,N''- 1,4- butanediylbis(N'- (3- isothiocyanatophenyl))thioureaIBA 12/2017 - 01/2016
2	Clopidogrel (Plavix)FDA Link 06/2017 - 05/2008
2	Phosphotransferases (Kinase)IBA 02/2015 - 01/2008
2	Minocycline (Cyclops)FDA LinkGeneric 09/2014 - 05/2009
2	Chemokine CCL3IBA 08/2014 - 06/2014
2	LigandsIBA 08/2014 - 06/2009
2	CC ChemokinesIBA 08/2014 - 06/2014
2	Cell Surface ReceptorsIBA 01/2013 - 11/2009
2	Gabapentin (Neurontin)FDA LinkGeneric 12/2012 - 11/2010
2	Adenosine (Adenocard)FDA LinkGeneric 09/2011 - 02/2004
2	src-Family KinasesIBA 07/2011 - 01/2008
2	Platelet Activating FactorIBA 01/2011 - 09/2007
2	cangrelorIBA 11/2010 - 05/2008
2	Phospholipases (Phospholipase)IBA 05/2010 - 11/2007
2	platelet activating factor receptorIBA 05/2010 - 09/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2009 - 01/2008
2	Phospholipases A2 (Phospholipase A2)IBA 05/2009 - 11/2007
2	U 0126 (UO 126)IBA 03/2008 - 09/2007
2	Protein Kinases (Protein Kinase)IBA 03/2008 - 09/2007
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2007 - 12/2005
2	OligodeoxyribonucleotidesIBA 01/2004 - 08/2003
1	LysophospholipidsIBA 01/2023
1	Calcium Channels (Calcium Channel)IBA 01/2023
1	Auranofin (Ridaura)FDA Link 01/2023
1	Secretory Phospholipases A2IBA 01/2023
1	CalciumIBA 01/2023
1	Therapeutic UsesIBA 12/2022
1	preproenkephalinIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	cilnidipineIBA 01/2021
1	Neuropeptide YIBA 01/2021
1	erythromycin propionate-N-acetylcysteinateIBA 07/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2020
1	AcetoneIBA 01/2020
1	Lipocalin-2IBA 01/2020
1	CpCpIBA 01/2020
1	Fulvestrant (Faslodex)FDA Link 10/2019

Therapy/Procedure

5	Therapeutics 11/2016 - 08/2003
4	Drug Therapy (Chemotherapy) 10/2019 - 11/2010
3	Oral Administration 01/2016 - 05/2008
3	Spinal Injections 06/2014 - 05/2006
2	Ligation 01/2022 - 11/2010
1	Transcranial Direct Current Stimulation 01/2022
1	Nerve Block (Nerve Blocks) 01/2022